Literature DB >> 6470030

Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients.

S Koga, N Kaibara, Y Iitsuka, H Kudo, A Kimura, H Hiraoka.   

Abstract

We performed intraoperative peritoneal cytology in 171 gastric cancer patients undergoing curative surgery. Intraperitoneal free cancer cells were demonstrated in almost all patients in whom the area of serosal cancer invasion exceeded 15-20 cm2. In patients with both serosal cancer invasion and free cancer cells the 5-year survival rat was 13% as compared with 85% for patients who had neither, and 40% for patients who had serosal invasion but no free peritoneal cancer cells. Peritoneal metastasis was the most frequently observed recurrence pattern. Therefore, in gastric cancer patients with marked serosal invasion, intraoperative IP administration of cytocidal anticancer drugs should be considered.

Entities:  

Mesh:

Year:  1984        PMID: 6470030     DOI: 10.1007/bf00402474

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  8 in total

1.  Assessment of the exfoliation of tumor cells into the body cavities.

Authors:  G E MOORE; K SAKO; T KONDO; J BADILLO; E BURKE
Journal:  Surg Gynecol Obstet       Date:  1961-04

2.  The prognostic value of peritoneal cytology in gynecologic malignant disease.

Authors:  W T Creasman; F Rutledge
Journal:  Am J Obstet Gynecol       Date:  1971-07-15       Impact factor: 8.661

3.  Viability of intraperitoneal free cancer cells in patients with gastric cancer.

Authors:  O Tanida; S Kaneshima; Y Iitsuka; H Kuda; Y Kiyasu; S Koga
Journal:  Acta Cytol       Date:  1982 Sep-Oct       Impact factor: 2.319

4.  [Evaluation of peritoneal lavage cytology at operation in 247 primary gastric cancer patients (author's transl)].

Authors:  K Miwa; M Yamagishi; H Kitamura; S Hagino; N Matsuki; A Yamaguchi; K Asano; M Noguchi; S Takashima; Y Takeshita; I Miyazaki; K Tanimoto; F Matsubara
Journal:  Nihon Gan Chiryo Gakkai Shi       Date:  1980-12-20

5.  Results of total gastrectomy for gastric cancer.

Authors:  S Koga; H Kishimoto; K Tanaka; Y Miyano; H Kawaguchi; R Takeda; H Nishidoi; O Kimura
Journal:  Am J Surg       Date:  1980-11       Impact factor: 2.565

6.  Intraperitoneal free cancer cells and their viability in gastric cancer.

Authors:  Y Iitsuka; S Kaneshima; O Tanida; T Takeuchi; S Koga
Journal:  Cancer       Date:  1979-10       Impact factor: 6.860

7.  Morphogenesis of peritoneal metastasis in human gastric cancer.

Authors:  Y Kiyasu; S Kaneshima; S Koga
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

8.  Chronologic comparison of postoperative results in gastric cancer surgery.

Authors:  S Koga; H Kishimoto; K Tanaka; H Kawaguchi; J Inoue
Journal:  Jpn J Surg       Date:  1978-12
  8 in total
  32 in total

1.  Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance.

Authors:  John Griniatsos; Othon Michail; Nikoletta Dimitriou; Ioannis Karavokyros
Journal:  World J Gastrointest Oncol       Date:  2012-02-15

2.  Risk of recurrence after laparoscopy-assisted radical gastrectomy for gastric cancer performed by a single surgeon.

Authors:  Sang-Ho Jeong; Young-Joon Lee; Soon-Tae Park; Sang-Kyung Choi; Soon-Chan Hong; Eun-Jung Jung; Young-Tae Joo; Chi-Young Jeong; Woo-Song Ha
Journal:  Surg Endosc       Date:  2010-11-12       Impact factor: 4.584

3.  Clinical importance of a transcription reverse-transcription concerted (TRC) diagnosis using peritoneal lavage fluids obtained pre- and post-lymphadenectomy from gastric cancer patients.

Authors:  Keijiro Sugimura; Yoshiyuki Fujiwara; Takeshi Omori; Masaaki Motoori; Norikatsu Miyoshi; Hirofumi Akita; Kunihito Gotoh; Shogo Kobayashi; Hidenori Takahashi; Shingo Noura; Masayuki Ohue; Takashi Yamamoto; Masato Sakon; Masahiko Yano
Journal:  Surg Today       Date:  2015-08-14       Impact factor: 2.549

Review 4.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.

Authors:  Ramakrishnan Ayloor Seshadri; Olivier Glehen
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 5.  Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.

Authors:  Hassan-Alaa-Hammed Al-Shammaa; Yan Li; Yutaka Yonemura
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

6.  Does the extent of lymph node dissection affect the postoperative survival of patients with gastric cancer and disseminating peritoneal metastasis?

Authors:  M Maeta; A Sugesawa; M Ikeguchi; S Tsujitani; H Yamashiro; S Shibata; A Kondo; N Kaibara
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

7.  Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen.

Authors:  Yasuhiro Kodera; Hayao Nakanishi; Seiji Ito; Yoshitaka Yamamura; Michitaka Fujiwara; Masahiko Koike; Kenji Hibi; Katsuki Ito; Masae Tatematsu; Akimasa Nakao
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

Review 8.  Intraperitoneal free cancer cells in gastric cancer: pathology of peritoneal carcinomatosis and rationale for intraperitoneal chemotherapy/hyperthermic intraperitoneal chemotherapy in gastric cancer.

Authors:  Zhong-He Ji; Kai-Wen Peng; Yan Li
Journal:  Transl Gastroenterol Hepatol       Date:  2016-09-19

Review 9.  Pathologic prognostic factors for gastrointestinal cancer.

Authors:  T Ismail; M T Hallissey; J W Fielding
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 10.  Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives.

Authors:  Yoshiyuki Fujiwara; Yuichiro Doki; Hirokazu Taniguchi; Itsuro Sohma; Shuji Takiguchi; Hiroshi Miyata; Makoto Yamasaki; Morito Monden
Journal:  Gastric Cancer       Date:  2007-12-25       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.